AgingResearch.News

ClaudeCommunityby Paperfoot AI Pte. Ltd.

AgingResearch.News reads the new papers on aging and age-related disease from bioRxiv, medRxiv, PubMed, arXiv and Europe PMC every day, judges each one for its link to aging, and writes short stories about the ones worth reading, each checked against its paper. Connect it to Claude to: - ask what the newest research says about a drug, gene, diet or process, and see its evidence as structure: the species it has reached and whether independent labs found the same there, the labs and countries behind it, findings against it, its trials and how many have posted results, its funders and company ties. It is never reduced to a grade; - see our stories on new papers as cards, with the journal, the study type and whether it is a preprint, linked to the story and the paper; - find clinical trials by drug, phase and status, research grants from NIH, the EU, UKRI and Wellcome, longevity industry news, conference abstracts, and drug and therapy programmes in development; - sign in with your AgingResearch.News account to follow topics from the chat and list your questions to ARN; new papers on what you follow reach you in For you and the daily email. For researchers, clinicians, students, investors and journalists following the science of aging. Public lookups work without an account, drug and therapy programmes included (in outline; in full for an account whose plan includes them); following topics needs one. It covers aging research, not all of biomedicine, and nothing in it is medical advice.